Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes
Clinical Gastroenterology and Hepatology · 2024
DOI: 10.1016/j.cgh.2023.11.034 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Marco Dioguardi Burgio und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Hôpital Beaujon, AP-HP Nord, Clichy, France; Université Paris Cité, INSERM, Centre de Recherche sur L'inflammation, Paris, F…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Magnetic Resonance Imaging. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Horizon 2020 Framework Programme, Université Paris Diderot, Servier.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Hôpital Beaujon, AP-HP Nord, Clichy, France; Université Paris Cité, INSERM, Centre de Recherche sur L'inflammation, Paris, France. Electronic address: marco.dioguardiburgio@aphp.fr.
- Departement of Hepatology, Hospital Beaujon, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Department of Radiology, Hôpital Beaujon, AP-HP Nord, Clichy, France.
- Université Paris Cité, INSERM, Centre de Recherche sur L'inflammation, Paris, France; Service d'Hépatologie, AP-HP, Hôpital Beaujon, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LI…
- Université Paris Cité, INSERM, Centre de Recherche sur L'inflammation, Paris, France; Department of Pathology, Hôpital Beaujon, AP-HP Nord, Clichy, France.
- Department of Pathology, Hôpital Beaujon, AP-HP Nord, Clichy, France.
Förderung
- Horizon 2020 Framework Programme
- Université Paris Diderot
- Servier
- Agence Nationale de la Recherche
- AbbVie
- Centre National de la Recherche Scientifique
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris Descartes
Zitieren
APA
Dioguardi Burgio, M., Castera, L., Oufighou, M., Rautou, P. E., Paradis, V., Bedossa, P., Sartoris, R., Ronot, M., Bodard, S., Garteiser, P., Van Beers, B., Valla, D., Vilgrain, V., Correas, J. M., & QUID – NASH Investigators (2024). Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.11.034
Vancouver
Dioguardi Burgio M, Castera L, Oufighou M, Rautou PE, Paradis V, Bedossa P, et al. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2023.11.034
BibTeX
@article{DioguardiBurgio2024,
author = {Dioguardi Burgio, Marco and Castera, Laurent and Oufighou, Mehdi and Rautou, Pierre-Emmanuel and Paradis, Valérie and Bedossa, Pierre and Sartoris, Riccardo and Ronot, Maxime and Bodard, Sylvain and Garteiser, Philippe and Van Beers, Bernard and Valla, Dominique and Vilgrain, Valérie and Correas, Jean Michel and QUID – NASH Investigators, QUID – NASH Investigators},
title = {Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
doi = {10.1016/j.cgh.2023.11.034}
}
EUVIMED